Summary
Tramadol is a cyclohexanol derivative with μ-agonist activity. It has been used as an analgesic for postoperative or chronic pain since the late 1970s, and became one of the most popular analgesics of its class in Germany. International interest has been renewed during the past few years, when it was discovered that tramadol not only acts on opioid receptors, but also inhibits serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine) reuptake. This review aims to provide a risk-benefit assessment of tramadol in the management of acute and chronic pain syndromes.
Tramadol has been used intraoperatively as part of balanced anaesthesia. Such use is under discussion, however, as it was associated with a high incidence of intraoperative recall and dreaming, and postoperative respiratory depression has been described after intraoperative administration of high doses.
Postoperatively, intravenous and intramuscular tramadol has been used with good efficacy. Analgesic doses were comparable with pethidine (meperidine) and 10 times higher than morphine. Nausea and vomiting were the most frequently reported adverse effects. In controlled studies, haemodynamic and respiratory parameters were only minimally impaired. The risk of severe respiratory depression in typical dosages is negligible in comparison with other opioids used for postoperative pain management.
Tramadol has been used with good results for the management of labour pain without respiratory depression of the neonate. It was also effective for the treatment of pain from myocardial ischaemia, ureteric colic and acute trauma.
Good results have been published for cancer pain management with tramadol in several studies. The potential for abuse or addiction seems to be minimal, and serious complications have not been reported. For patients with severe pain, the efficacy of morphine is superior, and most patients with adequate analgesia from tramadol had to be changed to a more potent opioid after a few weeks due to increased nociceptive input during tumour progression. Tramadol can be recommended as a safe and efficient drug for step II according to the World Health Organization guidelines for cancer pain management.
Similar content being viewed by others
References
Schenck EG, Arend I. Das Analgetikum Tramadol in der offenen klinischen Prüfung. Drug Res 1978; 28: 209–12
Keup W. Missbrauchmuster bei Abhängigkeit von Alkohol, Medikamenten und Drogen — Frühwarnsystem-Daten für die Bundesrepublik Deutschland 1976–1990. Freiburg im Breisgau: Lambertus Verlag, 1993: 116–20
Hennies HH, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Drug Res 1988; 38: 877–80
Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275–85
Collart L, Luthy C, Favario-Constantin C, et al. Dualité de l’effet analgésique du tramadol chez l’homme. Schweiz Med Wochenschr 1993; 123: 2241–3
Collart L, Luthy C, Dayer P. Partial inhibition of tramadol antinociceptive effect by naloxone in man [abstract]. Br J Clin Pharmacol 1993; 35: 73P
Raffa RB, Friderichs E, Reimann W, et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 267:331–40
Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 1994; 108: 806–11
Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992; 105: 147–51
Vaught JL, Codd EE, Connelly CD, et al. Tramadol, an atypical opioid analgesic: unexpected nonopioid component [abstract]. FASEB J 1991; 5: A473
Dayer P, Collart L, Desmeules J. The pharmacology of tramadol. Drugs 1994; 47 Suppl. 1:3–7
Collier HO, Dinneen LC, Johnson C, et al. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 1968; 32: 295–310
Eddy NB, Leimbach D. Synthetic analgesics: II. Dithienyl-butenyl- and dithienlbutylamines. J Pharmacol Exp Ther 1953; 107: 385–93
Desmeules J, Piquet V, Collart L, et al. Yohimbine antagonism as a tool to assess the extent of monoaminergic modulation in analgesic effect — experience with tramadol [abstract]. Experientia 1994; 50: A79
Desmeules J, Piquet V, Collart L, et al. Contribution of monoadrenergic modulation in tramadol analgesic effect [abstract]. Clin Pharmacol Ther 1994; 55: 151
Reimann W, Hennies HH. Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol. Biochem Pharm 1994; 47: 2289–93
Lintz W, Barth H, Osterloh G, et al. Bioavailability of enterai tramadol formulations. Drug Res 1986; 36: 1278–83
Lehmann KA, Kratzenberg U, Schroeder-Bark B, et al. Postoperative patient-controlled analgesia with tramadol: analgesic efficacy and minimum effective concentrations. Clin J Pain 1990; 6: 212–20
Hackl W, Ritzal S, Lackner F, et al. Vergleich von Fentanyl und Tramadol zur Schmerzbehandlung mittels On-Demand-Analgesie-Computer in der frühen postoperativen Phase. Anaesthesist 1986; 35: 665–71
Liao S, Hill JF, Nayk RK. Pharmacokinetics of tramadol following single and multiple oral doses in man [abstract]. Pharm Res 1992; 9 Suppl.: 308
Lintz W, Erlacin S, Frankus E, et al. Metabolismus von Tramadol bei Mensch und Tier. Drug Res 1981; 31: 1932–42
Raffa RB, Nayk RK, Liao S, et al. The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride. Rev Contemp Pharmacother 1995; 6: 485–97
Stoffregen J. Kombinationsnarkose mit Tramadol-Infusion. Anaesthesist 1980; 29: 673–4
Ellmauer S, Dick W, Otto S, et al. Verschiedene Opioide beim kardiovaskulären Risikopatienten. Anaesthesist 1994; 43: 743–9
Heid K. Erfahrungsbericht über 1100 Narkosen mit Tramadol. Anaesthesist 1984; 33: 665–71
Padmasuta K. The use of tramadol in analgesic-supplemented anesthesia. Curr Ther Res 1987; 41: 899–902
Paravicini D, Trauner K, Lawin P. Tramadol-Infusionsanaesthesie mit Substitution von Enfluran und differenten Lachgaskonzentrationen. Anaesthesist 1985; 34: 20–7
Rothhammer A, Weis KH, Skrobek W. Die klinische Brauchbarkeit der Tramadol-Infusionsnarkose. Anaesthesist 1981; 30:619–22
Seitz W, Kirchner E, Schaps D, et al. Endokrine Reaktionsmuster im Verlauf der einphasigen Tramadol-N2O Kombinationsnarkose. Anästh Intensivther Notfallmed 1982; 17: 325–31
Rothe KF, Brather R. Postoperative Atemdepressionen im Zusammenhang mit Tramadol-Infusionsnarkose? Anaesthesist 1983; 32: 88
Lehmann KA, Horrichs G, Hoeckle W. Zur Bedeutung von Tramadol als intraoperativem Analgetikum. Anaesthesist 1985; 34: 11–9
Chaturachinda K, Tangtrakul S, Pausawasdi S, et al. A comparative study of tramadol and pethidine in laparoscopic interval sterilization. J Med Assoc Thai 1988; 71 Suppl. 1: 55–7
Günther W. Anwendung von Tramadol-HCL als Adjuvans bei Regionalanaestesie. Reg Anesth 1982; 5: 20–1
Padmasuta K, Pausawasdi S, Tangtrakul S, et al. The efficacy of tramadol in the interval laparoscopic sterilization: a comparison of two dosage regimens. J Med Assoc Thai 1988; 71 Suppl. 2:61–3
Maier C, Kibbel K, Mercker S, et al. Postoperative Schmerztherapie auf allgemeinen Krankenpflegestationen. Anaesthesist 1994; 43: 385–97
Ure BM, Neugebauer E, Ullmann K, et al. Patientenkontrollierte Analgésie (PCA) zur postoperativen Schmerztherapie. Chirurg 1993; 64: 802–8
Cossmann M, Wilsmann KM. Behandlung länger andauernder Schmerzsyndrome: Beurteilung der Wirkung und Verträglichkeit von Tramadol bei mehrmaliger Gabe. Munch Med Wochenschr 1987; 129:851–4
Cossmann M, Wilsmann KM. Wirkung und Begleitwirkungen von Tramadol: offene Phase-IV-Prüfung mit 7198 Patienten. Therapiewoche 1987; 37: 3475–85
Cossmann M, Wilsmann KM. Anwendung der Tramadol-Injektionslösung beim akuten Schmerz: offene Prüfung zur Beurteilung der Akutwirkung und der Verträglickeit bei einmaliger parenteraler Anwendung. Munch Med Wochenschr 1988; 130: 633–8
Vickers MD, Paravicini D. Comparison of tramadol with morphine for post-operative pain following abdominal surgery. Eur J Anaesthesiol 1995; 12: 265–71
Stamer U, Maier C, Grond S, et al. Vergleich von Morphin, Tramadol und Placebo zur Therapie postoperativer Schmerzeneine randomisierte Doppelblindstudie [abstract]. Anaesthesist 1994; 43 Suppl. 1: S249
Alon E, Atanassoff PG, Biro P. Intravenöse postoperative Schmerzbehandlung mit Nalbuphin und Tramadol. Anaesthesist 1992; 41: 83–7
Vickers MD, O’Flaherty D, Szekely SM, et al. Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 1992; 47: 291–6
Lehmann KA, Jung C, Hoeckle W. Tramadol und Pethidin zur postoperativen Schmerztherapie: eine randomisierte Doppelblindstudie unter den Bedingungen der intravenösen On-Demand Analgesic. Eur J Pain 1985; 6: 88–100
Rodriguez MJ, De la Torre MR, Perez-Iraola P, et al. Comparative study of tramadol versus NSAIDs as intravenous continuous infusion for managing postoperative pain. Curr Ther Res 1993; 54: 375–83
Tryba M, Zenz M. Wirksamkeit und Nebenwirkungen von Opioiden und alpha-Adrenorezeptoragonisten in der Therapie postoperativer Schmerzen. Schmerz 1992; 6: 182–91
Houmes RJ, Voets MA, Verkaaik A, et al. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg 1992; 74: 510–4
Driessen A, Gorgass B, Glocke M. Vergleichende Untersuchungen zur postoperativen Schmerzbehandlung nach vaginalen Hysterektomien. Anästh Intensivmed 1984; 25: 26–9
Alon E, Schulthess G, Axhausen C, et al. Doppelblind-vergleichsstudie über die Wirkung von Tramadol und Buprenorphine auf die postoperativen Schmerzen. Anaesthesist 1981; 30: 623–6
Amin E, Tawfik O, Elboroglossy K. Tramadol hydrochloride in postoperative analgesia: a double blind comparison against butorphano tartrate and nalbuphine hydrochloride [abstract]. Pain 1990; 47 Suppl. 5:S186
Fassolt A. Zur Suppression von postoperativen Wundschmerzen mit Tramai (Tramadol) 100 mg i.m. Schweiz Rundschau Med 1981; 70: 435–40
Canepa G, Di Somma C, Ghia M, et al. Post-operative analgesia with tramadol: a controlled study compared with an analgesic combination. Int J Clin Pharm Res 1993; 13: 43–51
Stankov G, Schmieder G, Lechner FJ, et al. Observer-blind multicentre study with metamizole versus tramadol in postoperative pain. Eur J Pain 1995; 16: 56–63
Chrubasik J, Buzina M, Schulte-Mönting J, et al. Intravenous tramadol for post-operative pain - comparison of intermittent dose regimens with and without maintenance infusion. Eur J Anaesth 1992; 9: 23–8
Rüd U, Fischer MV, Mewes R, et al. Postoperative Analgésie mit Tramadol. Anaesthesist 1994; 43: 316–21
Jellinek H, Haumr H, Grubhofer G, et al. Tramadol zur postoperativen Schmerztherapie: patientenkontrollierte Analgésie versus kontinuierliche Infusion. Anaesthesist 1990; 39:513–20
Schäffer J, Piepenbrock S, Kretz FJ, et al. Nalbuphin und Tramadol zur postoperativen Schmerzbekämpfung bei Kindern. Anaesthesist 1986: 35: 408–13
Barsoum MW. Comparison of the efficacy and tolerability of tramadol, pethidine and nalbuphine in children with postoperative pain. Clin Drug Invest 1995; 9(4): 183–90
Mikhelson VA, Bikkulova DS, Tsypin LY, et al. Tramai in the treatment and prevention of the painful syndrome in children [in Russian], Anestezid Reanimatol 1994; 4: 21–4
Bikkulova DS. Pain control in the postoperative period assessed using an elaborated scale of subjective pain evaluation in children on tramai [in Russian]. Anestezid Reanimatol 1994; 2: 37–40
Ostreykov IF, Senkov VN, Kurilova ES, et al. Use of tramai during minor surgery in children [in Russian]. Anestezid Reanimatol 1993; 3: 28–31
Grond S, Meuser T, Zech D, et al. Analgesic efficacy and safety of tramadol enantiomers in comparison with the racemate: a randomised, double-blind study with gynaecological patients using intravenous patient-controlled analgesia. Pain 1995; 62:313–20
Stubhaug A, Grimstad J, Breivik H. Lack of analgesic effect of 50 and 100 mg tramadol after orthopaedic surgery: a randomized, double-blind, placebo and standard active drug comparison. Pain 1995; 62: 111–8
Sunshine A, Olson NZ, Zighelboim I, et al. Analgesic oral efficacy of tramadol hypochloride in postoperative pain. Clin Pharmacol Ther 1992; 51: 740–6
Kupers R, Callebaut V, Debois V, et al. Efficacy and safety of oral tramadol and pentazozine for postoperative pain following prolapsed intervertébral disc repair. Acta Anaesth Belgica 1995; 46: 31–7
Mehlisch D, Brown P, Lefner A, et al. Tramadol hydrochloride: short term efficacy in pain following dental surgery [abstract]. Clin Pharmacol Ther 1993; 53: 223
Fricke JR, Minn F, Cunningham BD. Tramadol HCL: dose response in pain from oral surgery [abstract]. Clin Pharmacol Ther 1991; 182
Moroz BT, Ignatov YD, Kalinin VI. Use of tramadol hydrochloride in therapeutic operative dentistry: clinical investigation. Curr Ther Res 1991; 49: 371–5
Delilkan AE, Vijayan R. Epidural tramadol for postoperative pain relief. Anaesthesia 1993; 48: 328–31
Baraka A, Jabbour S, Ghabash M, et al. A comparison of epidural tramadol and epidural morphine for postoperative analgesia. Can J Anaesth 1993; 40: 308–13
Chrubasik J, Warth L, Wüst H, et al. Untersuchungen zur analgetischen Wirksamkeit epidural applizierten Tramadols bei der Behandlung von Schmerzen nach abdominalchirurgischen Eingriffen. Eur J Pain 1988; 9: 12–8
Likar R, Mathiaschitz K, Burtscher M, et al. Randomised, double blind, comparative study of morphine and tramadol administered intra-articularly for postoperative analgesia following arthroscopic surgery. Clin Drug Invest 1995; 10(1): 17–21
Pausawasdi S, Jirasirithum S, Phanarai C. The use of tramadol hydrochloride in the treatment of postanesthetic shivering. J Med Assoc Thai 1990; 73: 16–20
Paravicini D, Schöngart C, Lawin P. Tramadol in der postoperativen Phase. Anästhesie Intensivther Notfallmed 1981; 16: 191–6
Paravicini D, Schöngart C, Lawin P. Untersuchungen liber analgetische Qualität und Nebenwirkungen des neuen Opioids Tramadol bei Patienten in der postoperativen Phase. Therapiewoche 1981; 31: 2948–52
Müller H, Stoyanov M, Brähler H, et al. Hämodynamische und respiratorische Effekte von Tramadol bei Lachgas-Sauerstoff-Beatmung und in der postoperativen Phase. Anaesthesist 1982; 31: 604–10
Klose R, Ehrhart A, Hung R. Der Enfluss von Buprenorphin und Tramadol auf die CO2-Antwort in der unmittelbaren postoperativen Phase nach Allgemeinanästhesie. Anästh Intensivther Notfallmed 1982; 17: 29–34
Fechner R, Racenberg E, Castor G. Klinische Untersuchungen über die Wirkung von Morphin, Pentazocin, Pethidin, Piritramid und Tramadol auf die Atmung. Anästhesiologie und Intensivmedizin 1985; 26: 126–31
Riedel F, Stockhausen H. Severe cerebral depression after intoxication with tramadol in a 6-month-old infant. Eur J Clin Pharmacol 1984; 26: 631–2
Bianchetti MG, Beutler A, Ferner PE. Intoxication sévère avec un opiacé (tramadol) chez un nourrisson de cinq semaines [in French]. Helv Paediatr Acta 1988; 43: 241–4
Fassolt A. Tramadol zur Schmerztherapie in der postoperativen Frühphase. Schweiz Rundsch Med Prax 1980; 69: 1495–500
Ofoegbu RE. Report on a clinical trial with tramadol hydrochloride (Tramai) in the prevention of post-operative pain. Curr TherRes 1984; 36: 436–44
Striebel HW, Hackenberger J. Vergleich einer Tramadol-Metamizol-Infusion mit der Kombination Tramadol-Infusion plus Ibuprofen-Suppositorien zur postoperativen Schmerz therapie nach Hysterektomien. Anaesthesist 1992; 41: 354–60
Lehmann KA, Brand-Stavroulaki A, Dworzak H. The influence of demand- and loading dose on the efficacy of postoperative patient-controlled analgesia with tramadol: a randomized double-blind study. Schmerz-Pain-Douleur 1986; 7: 146–52
Schäffer J, Hagemann H, Holzapfel S, et al. Untersuchungen zur postoperativen Schmerztherapie bei Kleinkindern mit Tramadol. Fortschr Anästh 1989; 3: 42–5
Carilo NB, Cordova S. A comparative clinical study of tramadol 100 mg versus tramadol 50 mg. Curr Ther Res 1992; 52: 112–20
Lagler F, Helm F, Etzel V, et al. Toxikologische Untersuchungen mit Tramadol, einem neuen Analgetikum. Drug Res 1978; 28: 164–80
J&J Ultram Dear Doctor letter advises of seizures and drug abuse. FDC Reports — Pink Sheet; 8 Apr 1996: T3&G 1
Medical evaluation of the spontaneous adverse event reports of seizures, anaphylactic reactions and abuse or dependence with tramadol. Grünenthal, May 1996
Barth H, Giertz H, Schmal A, et al. Anaphylactoid reactions and histamine release do not occur after application of the opioid tramadol. Agents Actions 1987; 20: 310–3
Cossmann M, Kohnen C. General tolerability and adverse event profile of tramadol hydrochloride. Rev Contemp Pharmacother 1995; 6: 513–31
Viegas OA, Khaw B, Ratnam SS. Tramadol in labour pain in primiparous patients: a prospective comparative clinical trial Eur J Obstet Gynecol Reprod Biol 1993; 49: 131–5
Kainz C, Joura E, Obwegeser R, et al. Wirksamkeit und Verträglichkeit von Tramadol mit oder ohne Antiemetikum sowie von Pethidin zur geburtshilflichen Analgésie. Z Geburtshilfe Perinat 1992; 196: 78–82
Bitsch M, Emmrich J, Hary J, et al. Geburtshilfliche Analgésie mit Tramadol. Fortschr Med 1980; 98: 632–43
Husslein P, Kubista E, Egarter C. Geburtshilfliche Analgésie mit Tramadol — Ergebnisse einer prospektiv randomisierten Vergleichsstudie mit Pethidine. Z Geburtshilfe Perinat 1987: 191:234–7
Prasertsawat PO, Herabuty Y, Chaturachinda K. Obstetric analgesia: comparison between tramadol, morphine and pethidine. Curr Ther Res 1986; 40: 1022–8
Suvonnakote T, Obst D, Thitadilok W, et al. Pain relief during labour. J Med Assoc Thai 1986; 69: 575–80
Richter W, von Arnim B, Giertz H. Tramadol-Kapseln in der klinischen Doppelblindprüfung. Munch Med Wochenschr 1981; 123:517–20
Schmieder G, Stankov G, Zerle G, et al. Observer-blind multicentre study with dipyrone versus tramadol and butylscopolamine in acute biliary colic pain. Drug Res 1993; 43: 1216–21
Stankov G, Schmieder G, Zerle G, et al. Double-blind study with dipyrone versus tramadol and butylscopolamine in acute renal colic pain. World J Urol 1994; 12: 155–61
Primus G, Pummer K, Vucsina F, et al. Tramadol versus Metamizol zur Schmerzausschaltung bei Ureterkolik. Urologe 1989; 28: 103–5
Staritz M, Poralla T, Manns M, et al. Effect of modem analgesic drugs (tramadol, pentazocine, and buprenorphine) on the bile duct sphincter in man. Gut 1986; 27: 567–9
Rettig G, Kropp J. Analgetische Wirkung von Tramadol beim akuten Myocardinfarkt. Therapiewoche 1980; 30: 5561–6
Karsch K, Wiegand V, Blandke H, et al. Wirkung eines neuen Analgetikums (Tramadol) auf die Hämodynamik bei Patienten mit koronarer Herzkrankheit. Z Kardiol 1979; 68: 599–603
Sommer F. Klinische Prüfung mit dem Analgetikum Tramadol-HCL Erfahrungsbericht aus einer orthopädischen Praxis. Extracta Med Pract 1981; 2: 826–31
Berghold F, Aufmesser H, Aufmesser W, et al. Erstversorgung von Wintersportverletzungen: analgetische Wirksamkeit und Verträglichkeit von Tramadol. Therapiewoche Österreich 1991; 6: 173–84
Wilder-Smith CH, Schimke J, Osterwalder B, et al. Oral tramadol, a μ-agonist and monamine reuptake-blocker, and morphine for strong cancer-related pain. Ann Oncol 1994; 5: 141–6
Von Lüben V, Müller H, Lobisch M, et al. Behandlung von Tumorschmerzen mit Flupirtin. Fortschr Med 1994; 112: 282–6
Osipova NA, Novikow GA, Beresnev VA, et al. Analgesic effect of tramadol in cancer patients with chronic pain: a comparison with prolonged-action morphine sulfate. Curr Ther Res 1991; 50:812–21
Tawfik MO, Elborolossy K, Nasr R. Tramadol hydrochloride in the relief of cancer pain: a double blind comparison against sustained release morphine [abstract]. Pain 1990;41 Suppl. 5: S377
Jensen EM, Ginsberg F. Tramadol versus dextropropoxyphene in the treatment of osteoarthritis. Drug Invest 1994; 8(4): 211–8
Theilade P. Death due to dextropropoxyphene: Copenhagen experiences. Forensic Sci Int 1989; 40: 143–51
Bird HA, Hill J, Stratford M, et al. A double blind cross-over study comparing the analgesic efficacy of tramadol with pentazocine in patients with osteoarthritis. J Drug Dev Clin Pract 1995; 7: 81–8
Goroll D. Tropfenform eines stark wirksamen Analgetikums in der Doppelblindprüfung. Med Klinik 1983; 78: 173–5
Rauck RL, Ruoff GE, McMillen JI. Comparison of tramadol and acetaminophen with codeine for long-term pain management in elderly patients. Curr Ther Res 1994; 55: 1417–31
von Arend I, von Armin B, Nijssen J, et al. Tramadol und Pentazocin im klinischen Doppelblind-Crossover-Vergleich. Drug Res 1978; 28: 199–208
Grond S, Zech D, Lynch J, et al. Tramadol — a weak opioid for relief of cancer pain. Pain Clin 1992; 5(4): 241–8
Grond S, Zech D, Meuser T, et al. Welche Bedeutung haben ‘schwache’ Opioide in der Tumorschmerztherapie — ‘high dose’ Tramadol vs. ‘low dose’ Morphin [abstract]. Anaesthesist 1992; 41 Suppl. 1: S152
Lenzhofer R, Moser K. Analgetische Wirkung von Tramadol bei Patienten mit malignen Erkrankungen. Wien Med Wochenschr 1984; 8: 199–202
Rodrigues N, Rodrigues Pereira E. Tramadol in cancer pain. Curr Ther Res 1989; 46: 1142–8
Zech D, Radbruch L, Hertel D, et al. Slow release tramadol for chronic malignant pain - an open multicenter clinical trial [abstract]. Br J Anaesthesia 1995; 74 Suppl. 1: S144
Murano T, Yamamoto H, Endo N, et al. Studies on dependence on tramadol in rats. Drug Res 1978; 28: 152–8
Yanagita T. Drug dependence potential of l-(m-Methosyphenyl)-2-(dimethylaminomethyl)-cyclohexan-1 -ol hydrochloride (tramadol) tested in monkeys. Drug Res 1978; 28: 158–63
Kayser V, Besson JM, Guilbud G. Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and crosstolerance to morphine. Eur J Pharmacol 1991; 195: 37–45
Cami J, Lamas X, Farré M. Acute effects of tramadol in methadone maintained volunteers. Drugs 1994; 47 Suppl. 1: 39–43
Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 1991; 27: 7–17
Flohé L, Arend I, Cogal A, et al. Klinische Prüfung der Abhängigkeitsentwicklung nach Langzeitapplikation von Tramadol. Drug Res 1978; 28: 213–7
Cesselin F, Laporte AM, Miquel MC, et al. Serotonergic mechanisms of pain control. In: Gebhart GF, Hammond DL, Jensen TS, editors. Progress in pain research and management. Vol. 2. Seattle: IASP Press, 1994
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Radbruch, L., Grond, S. & Lehmann, K.A. A Risk-Benefit Assessment of Tramadol in the Management of Pain. Drug-Safety 15, 8–29 (1996). https://doi.org/10.2165/00002018-199615010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199615010-00002